02:02 PM EDT, 04/10/2024 (MT Newswires) -- MoonLake Immunotherapeutics ( MLTX ) and Komodo Health said Wednesday that they signed a three-year partnership to improve treatment of inflammatory skin and joint diseases.

The agreement enables the companies to maximize the impact of MoonLake's therapy in hidradenitis suppurativa and active psoriatic arthritis, they said.

Financial details of the partnership weren't disclosed.

Price: 46.54, Change: -0.21, Percent Change: -0.45